High Cerebrospinal <scp>DOPA</scp> Decarboxylase Level Predicts Cognitive Decline in Parkinson's Disease
CSF DDC is a potential biomarker for the prediction of cognitive decline in PD patients.
Authors
- Wojciech Pasławski (ORCID: https://orcid.org/0000-0003-2141-4547)
- Per Svenningsson (ORCID: https://orcid.org/0000-0001-6727-3802)
- Shervin Khosousi
- Ioanna Markaki (ORCID: https://orcid.org/0000-0003-3328-5746)
- Hirotaka Iwaki (ORCID: https://orcid.org/0000-0002-8982-7885)
- Michael A. Nalls
- Andrew B. Singleton
- Andrea Sturchio
Institutions
- National Institutes of Health (US)
- Karolinska Institutet (SE)
- Data Tecnica International (United States) (US)
- National Institute of Neurological Disorders and Stroke (US)
- National Institute on Aging (US)
- University of Cincinnati (US)
Publication Details
- Journal
- Movement Disorders Clinical Practice
- Published
- 2025-09-24
- DOI
- https://doi.org/10.1002/mdc3.70367
- Citations
- 3
- Primary Topic
- Parkinson's Disease Mechanisms and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 4.17